RecruitingNot ApplicableNCT06243978
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria)
Effectiveness of a Digital Health Application for Primary Hypertension (Liebria): Randomized Controlled Trial
Sponsor
Gaia AG
Enrollment
328 participants
Start Date
Apr 2, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
This clinical trial with 328 patients with primary hypertension aims to investigate the effectiveness of the self-guided digital application liebria for patients with primary hypertension.
Eligibility
Min Age: 18 Years
Inclusion Criteria7
- Age ≥ 18
- Presence of primary hypertension, confirmed by submission of a medical certificate or equivalent (e.g., informal letter signed by primary care physician); relevant ICD-10-GM diagnoses:
- I10.00 (Benign essential hypertension: Without indication of hypertensive crisis)
- I10.90 (Essential hypertension, unspecified: Without indication of hypertensive crisis)
- Unmedicated or with existing antihypertensive drug therapy (with stable dose in the past 6 weeks prior to study enrolment)
- Last reported office-based systolic blood pressure (SBP) ≥ 140 mmHg followed by home-based SBP ≥ 135 mmHg
- Consent to participate
Exclusion Criteria4
- Home-based SBP \> 180 mmHg
- \> Triple combination of antihypertensive medication
- History of secondary hypertension (e.g., thyroid disease, kidney disease)
- Pregnancy
Interventions
BEHAVIORALliebria
Participants will receive access to the digital health intervention liebria in addition to TAU
OTHERinformation brochure on hypertension
Participants will receive an information brochure on hypertension
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06243978
Related Trials
BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT
NCT0605963898 locations
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
NCT070644731153 locations
Coaching and Navigation by Community Health Workers (CHWs) Through Telehealth for High-risk Hypertension
NCT074614154 locations
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT052937561 location
SGLT2i Improve Left Atrial Function in Patients With Paroxysmal Atrial Fibrillation, Hypertension and Abnormal Glucose Metabolism
NCT074820201 location